Warning: The NCBI web site requires JavaScript to function. more...
Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA).
Apicella C, Andrews L, Hodgson SV, Fisher SA, Lewis CM, Solomon E, Tucker K, Friedlander M, Bankier A, Southey MC, Venter DJ, Hopper JL.
Breast Cancer Res. 2003;5(6):R206-16. Epub 2003 Aug 28.
Related citations
Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K.
Clin Cancer Res. 2002 Dec;8(12):3776-81.
The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.
Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, Heching N, Peretz T.
Am J Hum Genet. 1997 Mar;60(3):505-14.
Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer.
Hodgson SV, Heap E, Cameron J, Ellis D, Mathew CG, Eeles RA, Solomon E, Lewis CM.
J Med Genet. 1999 May;36(5):369-73.
The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.
Hartge P, Struewing JP, Wacholder S, Brody LC, Tucker MA.
Am J Hum Genet. 1999 Apr;64(4):963-70.
BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.
Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet JS, Narod SA.
Am J Hum Genet. 2000 Apr;66(4):1259-72. Epub 2000 Mar 16.
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, Borgen P, Brown K, Skolnick M, Shattuck-Eidens D, Jhanwar S, Goldgar D, Offit K.
Nat Genet. 1996 May;13(1):126-8.
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H, Offit K.
Nat Genet. 1996 Oct;14(2):188-90.
A family with three germline mutations in BRCA1 and BRCA2.
Liede A, Metcalfe K, Offit K, Brown K, Miller S, Narod SA, Moslehi R.
Clin Genet. 1998 Sep;54(3):215-8.
A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers.
Levy-Lahad E, Lahad A, Eisenberg S, Dagan E, Paperna T, Kasinetz L, Catane R, Kaufman B, Beller U, Renbaum P, Gershoni-Baruch R.
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3232-6.
Analysis of BRCA1/BRCA2 genes' contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women.
Distelman-Menachem T, Shapira T, Laitman Y, Kaufman B, Barak F, Tavtigian S, Friedman E.
Fam Cancer. 2009;8(2):127-33. Epub 2008 Sep 17.
Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors.
Gotlieb WH, Friedman E, Bar-Sade RB, Kruglikova A, Hirsh-Yechezkel G, Modan B, Inbar M, Davidson B, Kopolovic J, Novikov I, Ben-Baruch G.
J Natl Cancer Inst. 1998 Jul 1;90(13):995-1000.
An evaluation of common breast cancer gene mutations in a population of Ashkenazi Jews.
Lalloo F, Cochrane S, Bulman B, Varley J, Elles R, Howell A, Evans DG.
J Med Genet. 1998 Jan;35(1):10-2.
Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
Roa BB, Boyd AA, Volcik K, Richards CS.
Nat Genet. 1996 Oct;14(2):185-7.
A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.
Berman DB, Costalas J, Schultz DC, Grana G, Daly M, Godwin AK.
Cancer Res. 1996 Aug 1;56(15):3409-14.
Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients.
Fodor FH, Weston A, Bleiweiss IJ, McCurdy LD, Walsh MM, Tartter PI, Brower ST, Eng CM.
Am J Hum Genet. 1998 Jul;63(1):45-51.
Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer.
Robson M, Dabney MK, Rosenthal G, Ludwig S, Seltzer MH, Gilewski T, Haas B, Osborne M, Norton L, Gilbert F, Offit K.
Genet Test. 1997;1(1):47-51.
Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
Shiri-Sverdlov R, Oefner P, Green L, Baruch RG, Wagner T, Kruglikova A, Haitchick S, Hofstra RM, Papa MZ, Mulder I, Rizel S, Bar Sade RB, Dagan E, Abdeen Z, Goldman B, Friedman E.
Hum Mutat. 2000 Dec;16(6):491-501.
Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.
Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E.
J Natl Cancer Inst. 1997 Feb 5;89(3):227-38.
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM, Offit K, Foulkes W, Robson ME, Wacholder S, Eng CM, Karp SE, Begg CB.
Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):467-73.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on